Pharvaris
Pharvaris is a Zug-based company focused on the development of oral bradykinin-B2-receptor antagonists.
3
Funding Rounds
$226.0m
Money raised
Overview
Pharvaris is a Zug-based company focused on the development of oral bradykinin-B2-receptor antagonists.
- Website:
- Business model: B2B
- Headquarters: Zug
- Social accounts: linkedin
Funding
Funding series
Funding Series Analysis
The company Pharvaris has raised a total of $146m in funding over 3 rounds.
Key Insights:
- Pharvaris November 2020 Series C Funding Round: $80m
- Pharvaris Series B round, September 2019: $66m
- Pharvaris Series C round November 2020: $80m
Pharvaris November 2020 Series C Funding Round
$80m
Pharvaris Series B round, September 2019
$66m
Pharvaris Series C round November 2020
$80m
Industries
Pharvaris is active in the following industries:
- Biomedical engineering
- Engineering
- Technology
- Biology
- Biotechnology
- Pharmaceutical industry
- Health technology
- Deep Tech